Pharmacodynamic Bioequivalence Study of Albuterol Sulfate Inhalation Aerosol, 0.09 mg Albuterol Base/ Inhalation
Condition:   Bronchial Asthma Interventions:   Other: Methacholine Chloride;   Drug: Albuterol Sulfate HFA 0.09 mg (Reference);   Drug: Albuterol Sulfate HFA 0.18 mg (Reference);   Drug: Albuterol Sulfate HFA 0.09 mg (Test);   Drug: Albuterol Sulfate HFA 0.18 mg (Test);   Drug: Placebo Sponsor:   Aurobindo Pharma Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 23, 2022 Category: Research Source Type: clinical trials

Levalbuterol Compared to Albuterol Regarding Cardiac Side Effects and Potassium Lowering Effects.
Condition:   Hyperkalemia Interventions:   Drug: Levalbuterol;   Drug: Albuterol Sponsor:   University of Aleppo Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 30, 2021 Category: Research Source Type: clinical trials